Hepatitis C Virus (HCV)–Specific Immune Responses of Long‐Term Injection Drug Users Frequently Exposed to HCV - Test2 - elhamkhani - TriplyDB

Hepatitis C Virus (HCV)–Specific Immune Responses of Long‐Term Injection Drug Users Frequently Exposed to HCV

Hepatitis C Virus (HCV)–Specific Immune Responses of Long‐Term Injection Drug Users Frequently Exposed to HCV

http://www.wikidata.org/entity/Q27488816

about

New perspectives in occult hepatitis C virus infection Cellular immune response to hepatitis-C-virus in subjects without viremia or seroconversion: is it important?Immune responses to HCV and other hepatitis viruses Viral Vaccines and CTL Response Protective immunity against hepatitis C: many shades of gray.Trace amounts of sporadically reappearing HCV RNA can cause infection Genetic variation in CLDN1 and susceptibility to hepatitis C virus infection Subinfectious hepatitis C virus exposures suppress T cell responses against subsequent acute infection.Consistent beneficial effects of killer cell immunoglobulin-like receptor 2DL3 and group 1 human leukocyte antigen-C following exposure to hepatitis C virus.Hepatitis C virus-specific T-cell immune responses in seronegative injection drug users Two distinct functional patterns of hepatitis C Virus (HCV)-specific T cell responses in seronegative, aviremic patients Loss of virus-specific T-cell responses in HCV exposed uninfected injection drug users with drug rehabilitation.Strong hepatitis C virus (HCV)-specific cell-mediated immune responses in the absence of viremia or antibodies among uninfected siblings of HCV chronically infected children.Early IL-10 predominant responses are associated with progression to chronic hepatitis C virus infection in injecting drug users.A polymorphism in IL28B distinguishes exposed, uninfected individuals from spontaneous resolvers of HCV infection.Favourable IFNL3 genotypes are associated with spontaneous clearance and are differentially distributed in Aboriginals in Canadian HIV-hepatitis C co-infected individuals.Molecular and contextual markers of hepatitis C virus and drug abuse.Hepatitis C virus-multispecific T-cell responses without viremia or seroconversion among Egyptian health care workers at high risk of infection.Hepatitis C virus-specific immune responses in noninjecting drug users.Incident Hepatitis B Virus Infection in HIV-Infected and HIV-Uninfected Men Who Have Sex With Men From Pre-HAART to HAART Periods: A Cohort Study.A case-control study of factors associated with resolution of hepatitis C viremia in former blood donors (CME)Occupational exposure to hepatitis C virus: early T-cell responses in the absence of seroconversion in a longitudinal cohort study.The hepatitis B vaccine protects re-exposed health care workers, but does not provide sterilizing immunity.Detection of HCV-Specific IFN-γ Responses in HCV Antibody and HCV RNA Negative Injecting Drug Users.Adaptive immunity to the hepatitis C virus.Complete definition of immunological correlates of protection and clearance of hepatitis C virus infection: a relevant pending task for vaccine development.Innate and adaptive genetic pathways in HCV infection.Host and viral determinants of the outcome of exposure to HCV infection genotype 4: a large longitudinal study.Exploration of potential mechanisms of hepatitis C virus resistance in exposed uninfected intravenous drug users.Anti-envelope antibody responses in individuals at high risk of hepatitis C virus who resist infection Differential distribution of IL28B.rs12979860 single-nucleotide polymorphism among Egyptian healthcare workers with and without a hepatitis C virus-specific cellular immune response.TCD8 response in diverse outcomes of recurrent exposure to hepatitis C virus.Correlates and characteristics of hepatitis C virus-specific T-cell immunity in exposed uninfected high-risk prison inmates.More rare birds, and the occasional swan.Cytokine profiles in high risk injection drug users suggests innate as opposed to adaptive immunity in apparent resistance to hepatitis C virus infection.Enhanced natural killer cell activity is found in exposed uninfected recipients of hepatitis C-contaminated blood.

P2860

Q22305491-4FF3FD04-F8C8-4948-AB0D-D2A87523047F Q26749249-4BC2854E-CF5A-4803-85CB-817645875AF9 Q26866955-7603582B-42B9-45B8-AAA3-693670BA2BDD Q27491330-6F24950D-2E09-409C-98DE-A69B364D5515 Q33759224-AF470252-8B2B-4242-B0E6-C233901BD3BB Q33944273-9F7B050F-B459-40F8-966A-E9AF19414FBB Q34064240-3E677629-F93B-4162-B536-130BF88E858A Q34336913-543E80E2-11E1-4B70-940C-927D5BD83BE5 Q34365617-6737AC57-D670-4D25-A498-F10B749F6A82 Q34381567-ED45B380-D01D-453B-A72D-2A5DB3C8DDC9 Q34701250-D714AD0A-2F0E-4FBF-98F9-5FB81F5DF79F Q34764010-0D833CE8-0B08-4E56-823C-E7317F1035F4 Q34764025-127965AD-BC41-406C-8BAD-3EEAA6231451 Q34777709-7D92DEC7-2AFE-40E7-A98F-060A35876A8E Q35356926-90395E39-F17D-4FA5-BE00-641FE12B122D Q35381792-783EB763-FDA7-4C91-86ED-C9EBB2DF153A Q35660841-56CEDA76-9C88-47D6-A6CE-63EE8A4377F4 Q35940716-551B3049-1CF1-4A82-8D13-82E7188D0850 Q36208809-40CF3303-6B97-4AC5-A299-E892292ED928 Q36240585-E92DED2F-9CE8-42BD-82AB-F9BB32802A75 Q36863802-DBC92C07-C4B3-4AE0-8E2B-5E0C42E9E98D Q37109539-AB0A1C85-5A13-4EC0-BE8E-2003FD488F8A Q37448838-5F95420E-E4EE-47D8-AD2D-E4485023AED0 Q37540482-A5B68C71-2459-4F37-AA28-A41886C2A33E Q37805839-9DCBB1B4-AAC4-409A-AD72-6D552B1D482B Q38010203-13B2E2E4-6236-40AA-88C7-03AE598C6BA2 Q38364524-1548CAB9-9FF2-4450-AF4C-FE90ECCB528B Q39117300-681F4B8C-954B-4D77-9277-0BC2C4D0044B Q39285745-D1A9BF13-B998-4820-A673-49B87F77AA44 Q40471338-F4F7044F-EBDB-49A6-BC6F-FD30755210CF Q40942638-6BF52BDC-23DD-46C0-9E4E-A68F466DB873 Q42987585-9562FE5C-19DD-4664-BEA6-25288BAC5339 Q42990115-DA7E5793-177F-46EF-843D-AC8BBEE0CEF9 Q43117957-B3C05590-82F1-4614-960C-BFE6667CDB9C Q44873304-288FF988-60E6-4275-964E-550E36D22D7A Q47602670-42330BF3-01F5-47F7-A634-AB770042CE16

P2860

Hepatitis C Virus (HCV)–Specific Immune Responses of Long‐Term Injection Drug Users Frequently Exposed to HCV

http://www.wikidata.org/entity/Q27488816

description

2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

article scientifique (publié 2008/07/15)

@fr

articolo scientifico (pubblicato il 2008/07/15)

@it

artigo científico (publicado na 2008/07/15)

@pt

artículu científicu espublizáu en 2008

@ast

im Juli 2008 veröffentlichter wissenschaftlicher Artikel

@de

scientific article (publication date: 15 July 2008)

@en

vedecký článok (publikovaný 2008/07/15)

@sk

videnskabelig artikel (udgivet 2008/07/15)

@da

name

Hepatitis C Virus (HCV)–Specif ...... sers Frequently Exposed to HCV

@ast

Hepatitis C Virus (HCV)–Specif ...... sers Frequently Exposed to HCV

@en

Hepatitis C Virus (HCV)–Specif ...... sers Frequently Exposed to HCV

@nl

type

label

Hepatitis C Virus (HCV)–Specif ...... sers Frequently Exposed to HCV

@ast

Hepatitis C Virus (HCV)–Specif ...... sers Frequently Exposed to HCV

@en

Hepatitis C Virus (HCV)–Specif ...... sers Frequently Exposed to HCV

@nl

prefLabel

Hepatitis C Virus (HCV)–Specif ...... sers Frequently Exposed to HCV

@ast

Hepatitis C Virus (HCV)–Specif ...... sers Frequently Exposed to HCV

@en

Hepatitis C Virus (HCV)–Specif ...... sers Frequently Exposed to HCV

@nl

P1433

Q27488816-74A2CC71-53C1-4569-A323-52FBF6474C7A

P1476

Q27488816-8FE05181-6783-4E33-BCC9-D8D136C0E231

P2093

Q27488816-28A26878-62DB-4F1D-B588-E9E6DD72E9E5

Q27488816-951951C9-24C7-4366-90FA-FAA004AB36A5

Q27488816-9F71CA2F-FA75-45A3-9F71-6A5476BE4F6D

Q27488816-A21C9E6B-01ED-4649-BB2A-CB027D4CE736

Q27488816-BA429154-7DFE-41C2-ACC4-62B5E820398C

Q27488816-CEA57528-1CCA-4C24-BD1B-982B0DD752E0

Q27488816-E991DE2D-6484-4D9E-9596-BCBE9FA9A8FB

P2860

Q27488816-07714CE8-53B4-4F9B-9B18-A7A863E60F8D

Q27488816-0BD6129D-50B9-456B-91D1-C05B382B7139

Q27488816-10FF3281-5BEE-4975-B055-824A06DE10A5

Q27488816-15D8D9BD-58C3-4CC7-84F7-6664A32BF635

Q27488816-1C6B5FC4-6C5B-4DC6-BD76-EFD90EAC5C00

Q27488816-22531C57-D849-4DA2-8513-2E2ABABCD348

Q27488816-2EE010AA-C7D5-43CA-9DA5-77BF97908812

Q27488816-34641C61-A7E3-4DE8-B6EE-69650044D83B

Q27488816-34B5F218-AA1C-4590-883C-4081915B8B33

Q27488816-35102221-AA8C-4E8B-80FC-D9761ECDE3F4

P304

Q27488816-BF06403F-D655-4231-8664-9A427798F33E

P31

Q27488816-41865525-39F1-4C2F-B3A9-1FF22686EE0F

P3181

Q27488816-17A53586-95FE-493E-BA29-6ABF226DE07D

P356

Q27488816-43FFC60E-63E4-41D2-8B0D-08EB166FCB7A

P407

Q27488816-DFFA9AA9-F8DA-4F4E-B6B3-263052F63BFD

P433

Q27488816-09D62337-E4BF-41DC-B278-0643076B688F

P478

Q27488816-7C4530AC-364F-4DB3-A24E-81DE3509420E

P50

Q27488816-12F111C6-0D62-43F5-AC90-9AB3BBC1C584

Q27488816-3E2C33B5-E764-44D1-8331-F9D0EE723AF3

Q27488816-47E0F87D-AB0B-4DA2-BC92-641E65C4F0F8

Q27488816-785E3D46-5E23-4BE7-845D-43C7B147080C

Q27488816-EBE84A0A-01F2-4AD2-B13E-C451DD8D3783

P577

Q27488816-0D757CE5-4A64-42C3-811B-FC5F43E72CA9

P5875

Q27488816-91647214-89E7-4492-9586-BB11C45AD584

P698

Q27488816-E315B744-784F-47E3-952A-66A0ACE00AEC

P932

Q27488816-2C8FB5CA-84B6-41D5-8444-F9820564A467

P3181

P356

P1433

The Journal of Infectious Diseases

P1476

Hepatitis C Virus (HCV)–Specif ...... sers Frequently Exposed to HCV

@en

P2093

Christina Weiler-Normann

http://www.w3.org/2001/XMLSchema#string

Christoph Eisenbach

http://www.w3.org/2001/XMLSchema#string

Eishiro Mizukoshi

http://www.w3.org/2001/XMLSchema#string

Kimberly P Newton

http://www.w3.org/2001/XMLSchema#string

Leslie H Tobler

http://www.w3.org/2001/XMLSchema#string

Sukanya Raghuraman

http://www.w3.org/2001/XMLSchema#string

Thomas R O'Brien

http://www.w3.org/2001/XMLSchema#string

P2860

Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes

Seroepidemiology of viral infections among intravenous drug users in northern California.

Detection of Diverse Hepatitis C Virus (HCV)-Specific Cytotoxic T Lymphocytes in Peripheral Blood of Infected Persons by Screening for Responses to All Translated Proteins of HCV

Efficiency of the Ortho VITROS Assay for Detection of Hepatitis C Virus-Specific Antibodies Increased by Elimination of Supplemental Testing of Samples with Very Low Sample-to-Cutoff Ratios

Comprehensive Analysis of CD8+-T-Cell Responses against Hepatitis C Virus Reveals Multiple Unpredicted Specificities

Kinetics of CD4+ and CD8+ Memory T-Cell Responses during Hepatitis C Virus Rechallenge of Previously Recovered Chimpanzees

Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles

Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C

Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection

In vitro assay for neutralizing antibody to hepatitis C virus: Evidence for broadly conserved neutralization epitopes

P304

203-12

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1616709

http://www.w3.org/2001/XMLSchema#string

P356

10.1086/589510

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

198

http://www.w3.org/2001/XMLSchema#string

P50

Jane A. McKeating

Barbara Rehermann

Mary Carrington

Michael P. Busch

P577

2008-07-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51393960

http://www.w3.org/2001/XMLSchema#string

P698

18505381

http://www.w3.org/2001/XMLSchema#string

P932

2699613

http://www.w3.org/2001/XMLSchema#string